TN2013000137A1 - Pharmaceutical compositions containing a dgat 1 inhibitor - Google Patents
Pharmaceutical compositions containing a dgat 1 inhibitorInfo
- Publication number
- TN2013000137A1 TN2013000137A1 TNP2013000137A TN2013000137A TN2013000137A1 TN 2013000137 A1 TN2013000137 A1 TN 2013000137A1 TN P2013000137 A TNP2013000137 A TN P2013000137A TN 2013000137 A TN2013000137 A TN 2013000137A TN 2013000137 A1 TN2013000137 A1 TN 2013000137A1
- Authority
- TN
- Tunisia
- Prior art keywords
- dgat
- inhibitor
- pharmaceutical compositions
- compositions containing
- properties
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a pharmaceutical composition comprising a) a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, b) one or more, e.g. 1, 2 or 3, surfactants with lubricant properties; c) one or more, e.g. 1, 2 or 3, dry binders with disintegrant properties; d) one or more, e.g. 1, 2 or 3, fillers, and e) one or more, e.g. 1, 2 or 3, disintegrants.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2011/056275 WO2012051488A1 (en) | 2010-10-14 | 2011-10-14 | Pharmaceutical compositions containing a dgat1 inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2013000137A1 true TN2013000137A1 (en) | 2014-06-25 |
Family
ID=54360805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2013000137A TN2013000137A1 (en) | 2011-10-14 | 2013-03-28 | Pharmaceutical compositions containing a dgat 1 inhibitor |
Country Status (1)
Country | Link |
---|---|
TN (1) | TN2013000137A1 (en) |
-
2013
- 2013-03-28 TN TNP2013000137A patent/TN2013000137A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013004162A (en) | Pharmaceutical compositions containing a dgat1 inhibitor. | |
MX2018001990A (en) | Compositions comprising a pi3k inhibitor and an hdac inhibitor. | |
TN2016000081A1 (en) | Aminoheteroaryl benzamides as kinase inhibitors | |
TN2015000121A1 (en) | Gdf-8 inhibitors | |
RS53301B (en) | Thioacetate compounds, compositions and methods of use | |
MY151003A (en) | Stable pharmaceutical composition comprising a pyrimidine-sulfamide | |
MY172924A (en) | Neprilysin inhibitors | |
GEP20146102B (en) | Compounds and compositions as protein kinase inhibitors | |
MX2013007336A (en) | Bi-heteroaryl compounds as vps34 inhibitors. | |
TN2009000049A1 (en) | A pyrrolopyrazin as syk-kinase inhibitor | |
GEP20146125B (en) | Aminopyrimidines as syk inhibitors | |
GEP20146146B (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
IN2012DN01233A (en) | ||
MY170935A (en) | Neprilysin inhibitors | |
MX354476B (en) | Neprilysin inhibitors. | |
MD4556C1 (en) | Catechol O-methyltransferase activity inhibiting compounds | |
MY187718A (en) | Pharmaceutical formulations | |
IN2014CN04530A (en) | ||
IN2014CN03803A (en) | ||
MX2011010311A (en) | Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same. | |
PH12015502802A1 (en) | Formulation comprising a hypolipidemic agent | |
MY151295A (en) | Pyrimidyl indoline compound | |
MY167898A (en) | Co-crystals and salts of ccr3-inhibitors | |
IN2012DN02502A (en) | ||
MX2009008028A (en) | Benzofuran antiparasitic agents. |